http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
Gut microbiota in neurologic and visceral diseases
Gut Microbiota in Neurologic and Visceral Diseases presents readers with comprehensive information on the involvement of microbiota in the pathogenesis of neurological disorders.
Intro -- Gut Microbiota In Neurologic and Visceral Diseases -- Copyright -- Dedication -- Contents -- Contributors -- Preface -- Acknowledgments -- Chapter 1: Gut microbiota: Implications on human health and diseases -- 1 Introduction -- 2 Classification -- 3 Factors affecting the composition of the gut microbiota -- 4 Functional aspects of the gut microbiota -- 4.1 Protection against pathogenic colonization (colonization resistance) -- 4.2 Maintenance of the intestinal epithelium integrity -- 4.3 Modulation of host metabolism -- 4.4 Influence on energy gain and expenditure -- 4.5 Host protection and immune-system development by gut microbiota -- 4.6 Gut microbiota-mediated modulation of host hypothalamic-pituitary-adrenal (HPA) axis -- 4.7 Gut microbiota-mediated alteration in the gut-brain axis (GBA) -- 4.8 Dysbiosis of the gut microbiota -- 5 Manipulation of the gut microbiota -- 6 Conclusion -- References -- Chapter 2: Effect of different types of diet patterns on the gut microbiota composition -- 1 Introduction -- 2 Microbiota-derived metabolites in host tissues -- 3 Effects of long-term consumption of various types of diets on the host -- 4 Effects of long-term consumption of the Western diet -- 5 Effects of long-term consumption of the Mediterranean diet -- 6 Effects of long-term consumption of the vegetarian diet -- 7 Effects of long-term consumption of the ketogenic diet -- 8 Conclusion -- References -- Chapter 3: Importance of fiber in human diet: Contribution of microbiota in human health -- 1 Introduction -- 2 Beneficial effects of dietary fiber consumption on human health -- 3 Gut microbiota and human health -- 4 Effects of gut microbiota-derived metabolite in host tissues -- 5 Role of microbiota-derived short-chain fatty acids -- 6 Role of microbiota-derived trimethylamine and trimethylamine- N -oxide.
7 Role of tryptophan and its metabolites in metabolism -- 8 Conclusion -- References -- Chapter 4: Importance of fermented foods on human health -- 1 Introduction -- 2 Beneficial effects of fermented foods -- 3 Importance of fermented foods on human health -- 3.1 Consumption of kefir -- 3.2 Consumption of dairy products (yogurt and cheese) -- 3.3 Consumption of kombucha -- 3.4 Consumption of sauerkraut -- 3.5 Consumption of tempeh -- 3.6 Consumption of miso -- 3.7 Consumption of nattō -- 3.8 Consumption of kimchi -- 4 Adverse effects of fermented foods -- 5 Conclusion -- References -- Chapter 5: Contribution of gut microbiota in the pathogenesis of amyotrophic lateral sclerosis and Huntington's disease -- 1 Introduction -- 2 Pathogenesis of familial ALS -- 3 Involvement of the kynurenine pathway in the pathogenesis of sporadic ALS -- 4 Contribution of gut microbiota in the pathogenesis of amyotrophic lateral sclerosis -- 5 Molecular mechanisms contributing to neurodegeneration in Huntington's disease -- 6 Contribution of gut microbiota in Huntington's disease -- 7 Conclusion -- References -- Chapter 6: The gut microbiome in neurodegenerative disorders -- 1 Introduction -- 2 The microbiome: Development and function -- 3 Overview of the gut-brain axis -- 4 Microbiota-gut-brain axis -- 5 Microbiota and neurodegenerative diseases -- 5.1 Microbiota and Alzheimer's disease -- 5.2 Parkinsońs disease -- 5.3 Huntingtońs disease -- 5.4 Amyotrophic lateral sclerosis -- 5.5 Multiple sclerosis -- 6 Role of diet in the microbiome and neurodegenerative disease -- 7 Potential therapies -- 8 Conclusion -- References -- Chapter 7: The contribution of gut microbiota in the pathogenesis of Parkinson's disease -- 1 Introduction -- 2 Gut microbiota dysbiosis in Parkinson's disease.
3 Microbiota gut-brain axis role in Parkinson's disease -- 4 Synuclein propagation from gut to brain -- 5 Targeting of GBA in Parkinson's disease by probiotics, prebiotics, and/or symbiotics -- 6 Conclusion -- References -- Chapter 8: The contribution of microbiota, cerebral blood flow, and sleep deprivation in the pathogenesis of Alzheimer's d ... -- 1 Introduction -- 2 Factors affecting human gut microbiota -- 3 Effect of microbiota on immune system -- 4 Contribution of microbiota in the pathogenesis of Alzheimer's disease -- 5 Association of cerebral blood flow in Alzheimer's disease -- 6 Contribution of sleep deprivation in the pathogenesis of Alzheimer's disease -- 7 Conclusion -- References -- Chapter 9: Implications of microbiota in the pathogenesis of diabetes mellitus and cardiovascular disease -- 1 Introduction -- 2 Microbiota and diabetes -- 2.1 Type 2 diabetes -- 2.2 Type 1 diabetes -- 3 Microbiota and cardiovascular disease -- 3.1 Atherosclerosis -- 3.2 Acute coronary syndrome -- 3.3 Atrial fibrillation -- 3.4 Heart failure -- 3.5 Arterial hypertension -- 4 Investigative tools -- 5 Treatment and future perspective -- 5.1 Diabetes -- 5.2 Cardiovascular disease -- 6 Conclusion -- References -- Chapter 10: Link between gut microbiome and cardiometabolic diseases -- 1 Introduction -- 2 CMDs -- 3 Effects of diet on gut microbiota -- 4 Gut microbial dysbiosis -- 5 Gut microbial dysbiosis and CMDs -- 5.1 Microbial dysbiosis and obesity -- 5.2 Microbial dysbiosis and diabetes -- 5.3 Microbial dysbiosis and NAFLD -- 5.4 Microbial dysbiosis and atherosclerosis -- 5.5 Microbial dysbiosis and hypertension -- 5.6 Microbial dysbiosis and congestive heart failure -- 6 Conclusion -- References -- Chapter 11: Contribution of microbiota in obesity and obesity-related chronic diseases -- 1 Introduction.
2 Molecular mechanism of obesity -- 3 Effects of diet and microbiota on chronic diseases -- 4 Obesity, microbiota composition, and type2 diabetes -- 5 Obesity, microbiota, and metabolic syndrome -- 6 Obesity, microbiota, and cardiovascular disease -- 7 Obesity, microbiota, and neurological disorders -- 8 Conclusion -- References -- Chapter 12: Contribution of microbiota in the pathogenesis of ischemic stroke -- 1 Introduction -- 2 Molecular aspects of ischemic stroke -- 3 Contribution of gut microbiota in poststroke injury -- 4 Conclusion -- References -- Chapter 13: Bioactive lipids and gut microbiota interact to regulate health and disease -- 1 Introduction -- 2 Essential fatty acids and their clinical significance -- 3 EFA deficiency suppresses autoimmune diseases: But how and why? -- 4 Gut microbiota -- 5 Potential interaction between EFAs, their metabolites and gut microbiota -- 6 BALs influence gut microbiota -- 7 Conclusion -- References -- Chapter 14: Contribution of gut microbiota and multiple organ failure in the pathogenesis of COVID-19 infection -- 1 Introduction -- 2 COVID-19 infection associated changes in respiratory tract and lungs -- 3 COVID-19 associated changes in gut microbiota and digestive tract -- 4 COVID-19 infection associated changes in cardiovascular system -- 5 COVID-19 associated changes in kidney -- 6 Role of cytokine storm and multiple organ failure in COVID-19 associated death -- 7 Conclusion -- References -- Chapter 15: Contribution of gut microbiota in the pathogenesis of migraine headache -- 1 Introduction -- 2 Theories underlying migraine headache -- 2.1 Vascular theory due to cerebral vasodilation -- 2.2 Cortical spreading depression and migraine -- 2.3 The trigeminovascular system and migraine -- 2.4 Microbiota gut-brain axis and migraine -- 3 Gut microbiota dysbiosis and migraine.
4 Gastrointestinal disorders, gut microbiota dysbiosis, and migraine -- 4.1 H. pylori infection, gut microbiota dysbiosis, and migraine -- 4.2 Inflammatory bowel disease, gut microbiota dysbiosis, and migraine -- 4.3 IBS, gut microbiota dysbiosis, and migraine -- 4.4 CD, gut microbiota dysbiosis, and migraine -- 4.5 Gastroparesis, gut microbiota dysbiosis, and migraine -- 4.6 Infantile colic, gut microbiota dysbiosis, and migraine -- 5 The gut-brain axis and migraine -- 6 Conclusion -- References -- Chapter 16: Insights on the modulatory role of Ayurveda-based herbal preparations on gut microbiome and neuroprotection -- 1 Introduction -- 2 Gut microbes and brain health -- 2.1 Gut microbiome (GM) -- 2.2 Gut Microbiota and NDD -- 2.3 GM-derived metabolites -- 2.4 GM modulation: Existing approaches -- 2.5 Modulation of GM by phytochemicals -- 3 Evidence of GM involvement in specific NDD -- 3.1 Evidence of involvement GM-PD and HD -- 3.2 Evidence of involvement of GM: Alzheimer's disease (AD) -- 3.3 Flavonoids and GM -- 3.4 Curcumin, GM, and NDD -- 3.5 Spice herbs and neuroprotection -- 4 Ayurveda and NDD -- 4.1 Ayurvedic preparations: Concept of Triphala -- 4.2 Polyherbalism-Polyherbal formulations (PHFs) -- 4.3 Triphala and modulation of GM -- 4.4 Nanoformulations of herbal extracts and NDD -- 5 Recent approaches in microbiome research -- 5.1 Gut microbiome in human populations -- 5.2 Ayurgenomics: Ayurvedic approach -- 6 Conclusions and future perspective -- Acknowledgment -- References -- Chapter 17: The emerging roles of gut microbiome on neurotoxic outcomes: Implications for neurological disorders -- 1 Introduction -- 2 The link between gut and brain -- 3 Neurotoxicity-microbiota interactions -- 3.1 Microbial transformation of neurotoxicants -- 3.2 Microbial regulation of neuroactive metabolites.
edited by Tahira Farooqui and Akhlaq A. Farooqui.